'Obese people often rebound to their former weights when they cease treatments and diet regimens. The British NHS has placed a two-year limit on injectables as obesity treatments, but what happens then? Pharma companies are preparing for a battle to keep on getting paid.'

https://www.ft.com/content/cb26c3df-29be-437f-b98a-d2511b212083